Description
Genvoya 150mg/200mg/10mg Online
Genvoya (Elvitegravir Cobicistat Emtricitabine and Tenofovir Alafenamide) 150mg/200mg/10mg Online
Genvoya is indicated as a complete regimen for the treatment of HIV-1 infection in adults and pediatric patients 12 years of age and older who have no antiretroviral treatment history or to replace the current antiretroviral regimen in those who are virologically-suppressed (HIV-1 RNA less than 50 copies per mL) on a stable antiretroviral regimen for at least 6 months with no history of treatment failure and no known substitutions associated with resistance to the individual components of Genvoya.
Genvoya is a tablet containing a combination of Cobicistat (Genvoya), Elvitegravir (Genvoya), Emtricitabine (Genvoya), and tenofovir. Cobicistat (Genvoya) reduces the action of enzymes in your liver that break down certain antiviral medicines. This allows the antiviral medicines to be used more safely and effectively at lower doses. Elvitegravir (Genvoya), Emtricitabine (Genvoya), and tenofovir are antiviral drugs that prevent HIV (human immunodeficiency virus) cells from multiplying in the body. HIV can cause acquired immunodeficiency syndrome (AIDS). Genvoya is a complete regimen for the treatment of HIV-1 infection; therefore, coadministration of Genvoya with other antiretroviral medications for the treatment of HIV1 infection should be avoided. Complete information regarding potential drug-drug interactions with other antiretroviral medications is not provided.
